首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

mRNA療法市場規模、佔有率和成長分析（按類型、應用、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1904270

mRNA療法市場規模、佔有率和成長分析（按類型、應用、最終用戶和地區分類）—2026-2033年產業預測

mRNA Therapeutics Market Size, Share, and Growth Analysis, By Type (Prophylactic, Therapeutic), By Application (Infectious Diseases, Oncology), By End-user, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，mRNA 療法市場規模將達到 117.2 億美元，到 2025 年將達到 124.8 億美元，到 2033 年將達到 206.5 億美元，在預測期（2026-2033 年）內複合年成長率為 6.5%。

市場趨勢表明，基於mRNA的療法正成為治療慢性疾病的有力解決方案，推動該領域強勁成長。與DNA疫苗相比，mRNA疫苗在生產和分銷方面均具有優勢，使其成為醫療保健領域更安全的選擇。尤其是在新冠肺炎疫情期間，由Moderna和輝瑞-BioNTech等主要企業主導的成功人體臨床試驗進一步加速了這類療法的需求。此外，正在進行的腫瘤臨床試驗表明，人們對mRNA在感染疾病以外的應用也越來越感興趣。 mRNA穩定性、翻譯和遞送技術的進步證實了其潛力，使其成為個人化醫療的變革性工具，並重新定義了醫療保健標準，從而進一步推動了未來市場對mRNA產品的需求。

mRNA療法市場促進因素

mRNA技術的出現徹底改變了疫苗研發格局，尤其是在感染疾病領域。 mRNA疫苗的快速發展和成功應用，展現了其作為應對健康危機的高效解決方案的巨大潛力。這種創新方法能夠對新出現的病原體做出快速反應，體現了mRNA療法的多功能性和適應性。因此，人們對mRNA技術的興趣和投資激增，使其成為持續對抗各種感染疾病的關鍵組成部分，並最終推動了mRNA療法市場的成長和擴張。

限制mRNA療法市場的因素

mRNA療法市場面臨許多重大挑戰，尤其是在生產和分銷環節。其中一個主要障礙在於，如何在確保穩定高效供應鏈的同時，擴大mRNA產能。全球健康危機進一步加劇了這個問題，凸顯了基礎設施和物流的脆弱性。因此，該領域的企業必須在滿足日益成長的mRNA治療方法需求的同時，應對複雜的監管環境，並克服採購高品質原料的重重困難。這些因素共同阻礙因素了市場的整體成長潛力。

mRNA治療藥物市場趨勢

mRNA療法市場正經歷顯著的上升趨勢，尤其是在mRNA癌症疫苗的研發方面，這些疫苗正在革新腫瘤治療領域。這些創新疫苗利用人體自身的細胞機制來誘發針對癌細胞的強效免疫反應，從而有望實現更個人化、更有效的治療。隨著該領域研究的不斷深入，生物技術公司與學術機構之間的合作日益加強，加速了創新進程，並改善了臨床試驗結果。這種不斷變化的模式為投資和患者照護的進步提供了巨大的機遇，並將mRNA技術定位為未來癌症治療的基礎。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Lonza Group（Switzerland）
Samsung Biologics（South Korea）
Fujifilm Diosynth Biotechnologies（Japan）
Catalent（United States）
BioNTech（Germany）
Ionis Pharmaceuticals（United States）
WuXi Biologics（China）
CordenPharma（Germany）
WuXi AppTec（China）
Boehringer Ingelheim（Germany）
Samsung Biologics（South Korea）
WuXi Biologics（China）
WuXi AppTec（China）
Boehringer Ingelheim（Germany）
WuXi Biologics（China）
WuXi AppTec（China）
Boehringer Ingelheim（Germany）
WuXi Biologics（China）
WuXi AppTec（China）
Boehringer Ingelheim（Germany）

結論與建議

簡介目錄

Product Code: SQMIG35A2547

mRNA Therapeutics Market size was valued at USD 11.72 Billion in 2024 and is poised to grow from USD 12.48 Billion in 2025 to USD 20.65 Billion by 2033, growing at a CAGR of 6.5% during the forecast period (2026-2033).

Market insights indicate that mRNA-based therapeutics are emerging as powerful solutions for chronic conditions, driving robust growth in this sector. Compared to DNA vaccines, mRNA vaccines offer advantages in both production and distribution, establishing a safer alternative in the healthcare landscape. The successful outcomes of human clinical trials have further fueled demand for these therapeutics, particularly during the COVID-19 pandemic, largely influenced by key players like Moderna and Pfizer-BioNTech. Additionally, ongoing oncology clinical trials highlight an expanding interest in mRNA applications beyond infectious diseases. Technological advancements in stability, translation, and delivery of mRNA underscore its potential, positioning it as a transformative tool in personalized medicine and redefining healthcare standards, thus elevating future market demand for mRNA products.

Top-down and bottom-up approaches were used to estimate and validate the size of the mRNA Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

mRNA Therapeutics Market Segments Analysis

Global mRNA Therapeutics Market is segmented by Type, Application, End-user and region. Based on Type, the market is segmented into Prophylactic and Therapeutic. Based on Application, the market is segmented into Infectious Diseases, Oncology, Rare Genetic Diseases,respiratory diseasesand Others. Based on End-user, the market is segmented into Hospitals & Clinics, Research Organizations and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the mRNA Therapeutics Market

The emergence of mRNA technology has significantly transformed the landscape of vaccine development, particularly in the context of infectious diseases. The rapid advancement and successful deployment of mRNA vaccines have demonstrated their potential as highly effective and efficient solutions to health crises. This innovative approach offers a swift response to emerging pathogens, showcasing the versatility and adaptability of mRNA therapeutics. As a result, the interest and investment in mRNA technology have surged, positioning it as a vital component in the ongoing fight against various infectious diseases, ultimately driving growth and expansion within the mRNA therapeutics market.

Restraints in the mRNA Therapeutics Market

The mRNA therapeutics market faces several significant challenges, particularly related to the production and distribution processes. One of the primary obstacles is the difficulty in scaling up production capacity for mRNA while ensuring a stable and efficient supply chain. This issue has been exacerbated by global health crises, which have highlighted vulnerabilities in infrastructure and logistics. As a result, companies in this sector must navigate complex regulatory landscapes and manage the intricacies of sourcing high-quality materials, all while striving to meet the increasing demand for mRNA-based therapies. These factors contribute to the overall restraint in the market's growth potential.

Market Trends of the mRNA Therapeutics Market

The mRNA therapeutics market is experiencing a significant upward trend, particularly in the development of mRNA cancer vaccines, which are revolutionizing oncology. These innovative vaccines harness the body's own cellular machinery to elicit robust immune responses against cancer cells, offering the potential for more personalized and effective treatments. As research in this area expands, the collaboration between biotech firms and academic institutions is intensifying, leading to accelerated innovation and enhanced clinical trial outcomes. This evolving landscape presents substantial opportunities for investment and advancements in patient care, positioning mRNA technology as a cornerstone in the future of cancer therapeutics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis

Global mRNA Therapeutics Market Size by Type & CAGR (2026-2033)

Market Overview
Prophylactic
Therapeutic

Global mRNA Therapeutics Market Size by Application & CAGR (2026-2033)

Market Overview
Infectious Diseases
Oncology
Rare Genetic Diseases
Respiratory Diseases
Others

Global mRNA Therapeutics Market Size by End-user & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Research Organizations
Others

Global mRNA Therapeutics Market Size & CAGR (2026-2033)

North America (Type, Application, End-user)
- US
- Canada
Europe (Type, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Samsung Biologics (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Diosynth Biotechnologies (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Catalent (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioNTech (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ionis Pharmaceuticals (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi Biologics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CordenPharma (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Samsung Biologics (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi Biologics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi Biologics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi Biologics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments